🔥🐔 BizChicken 🐔🔥
Companies Similar to Summit Therapeutics Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Cyclerion Therapeutics, Inc.
CY6463
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing medicines for serious CNS diseases, with products like CY6463 for mitochondrial encephalomyopathy and Alzheimer's disease.
Symbol: CYCN
Recent Price: $3.45
Industry: Biotechnology
CEO: Dr. Regina Graul Ph.D.
Sector: Healthcare
Employees: 1
Address: 245 First Street, Cambridge, MA 02142
Phone: 857 327 8778
Last updated: 2024-12-31
Fulcrum Therapeutics, Inc.
losmapimod and FTX-6058
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing products to improve the lives of patients with genetically defined diseases in areas of high unmet medical need in the United States.
Symbol: FULC
Recent Price: $4.68
Industry: Biotechnology
CEO: Mr. Alexander C. Sapir
Sector: Healthcare
Employees: 76
Address: 26 Landsdowne Street, Cambridge, MA 02139
Phone: 617 651 8851
Last updated: 2024-12-31
Shuttle Pharmaceuticals Holdings, Inc.
Ropidoxuridine, Doranidazole
Shuttle Pharmaceuticals Holdings, Inc. focuses on the discovery, development, and commercialization of drugs aimed at sensitizing cancers to radiation therapy, with products such as Ropidoxuridine and Doranidazole in clinical stages.
Symbol: SHPH
Recent Price: $0.77
Industry: Drug Manufacturers - Specialty & Generic
CEO: Dr. Anatoly Dritschilo M.D.
Sector: Healthcare
Employees: 8
Address: One Research Court, Rockville, MD 20850
Phone: 240 403 4212
Last updated: 2024-12-31
Oncternal Therapeutics, Inc.
zilovertamab, ONCT-216, ONCT-808, ONCT-534
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.
Symbol: ONCT
Recent Price: $0.53
Industry: Biotechnology
CEO: Dr. James B. Breitmeyer M.D., Ph.D.
Sector: Healthcare
Employees: 27
Address: 12230 El Camino Real, San Diego, CA 92130
Phone: 858 434 1113
Last updated: 2024-12-31
Revelation Biosciences, Inc.
REVTx-99b
Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing immune system therapeutics and diagnostics, including products for chronic nasal congestion, allergic rhinitis, chronic organ disease, and viral infections.
Symbol: REVB
Recent Price: $0.39
Industry: Biotechnology
CEO: Mr. James M. Rolke
Sector: Healthcare
Employees: 9
Address: 4660 La Jolla Village Drive, San Diego, CA 92122
Phone: 650-800-3717
Last updated: 2024-12-31
Tonix Pharmaceuticals Holding Corp.
TNX-1500, TNX-2900, TNX-801, TNX-1840, TNX-1850, TNX-3500
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company that focuses on developing therapies for immunology, rare diseases, infectious diseases, and central nervous system disorders. Key products include TNX-1500 for organ transplant and autoimmune diseases, TNX-2900 for Prader-Willi syndrome, and TNX-801 for smallpox prevention.
Symbol: TNXP
Recent Price: $0.36
Industry: Biotechnology
CEO: Dr. Seth Lederman M.D.
Sector: Healthcare
Employees: 103
Address: 26 Main Street, Chatham, NJ 07928
Phone: 862 799 8599
Last updated: 2024-12-31
Biomerica, Inc.
diagnostic and therapeutic products
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.
About | About | Contact | Contact | About | News | News | About | About | About | About | About
Symbol: BMRA
Recent Price: $0.31
Industry: Medical - Devices
CEO: Mr. Zackary S. Irani
Sector: Healthcare
Employees: 64
Address: 17571 Von Karman Avenue, Irvine, CA 92614
Phone: 949 645 2111
Last updated: 2024-12-31
Cidara Therapeutics, Inc.
rezafungin acetate
Cidara Therapeutics, Inc. is a biotechnology company focused on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology. Their lead product candidate is rezafungin acetate, a novel echinocandin antifungal for treating invasive fungal infections.
Symbol: CDTX
Recent Price: $25.25
Industry: Biotechnology
CEO: Dr. Jeffrey L. Stein Ph.D.
Sector: Healthcare
Employees: 69
Address: 6310 Nancy Ridge Drive, San Diego, CA 92121
Phone: 858 752 6170
Last updated: 2024-12-31
Cumberland Pharmaceuticals Inc.
Acetadote, Caldolor, Kristalose, Omeclamox-Pak, Vaprisol, Vibativ, Redi Trex
Cumberland Pharmaceuticals Inc. focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology, offering various medications including injections and oral solutions.
Symbol: CPIX
Recent Price: $2.42
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. A. J. Kazimi MBA
Sector: Healthcare
Employees: 91
Address: 2525 West End Avenue, Nashville, TN 37203
Phone: 615 255 0068
Last updated: 2024-12-31
Eloxx Pharmaceuticals, Inc.
ELX-02
Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing ribosome modulation therapies for rare and ultra-rare premature stop codon diseases. The company's lead investigational drug, ELX-02, is in Phase 2 clinical trials for cystic fibrosis and nephropathic cystinosis.
Symbol: ELOX
Recent Price: $0.00
Industry: Biotechnology
CEO: Mr. Sumit Aggarwal M.B.A.
Sector: Healthcare
Employees: 18
Address: 480 Arsenal Way, Watertown, MA 02472
Phone: 781 577 5300
Last updated: 2024-12-31
Phio Pharmaceuticals Corp.
INTASYL therapeutic platform
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics using its INTASYL therapeutic platform to target tumor and immune cells by regulating genes of the immune system, focusing on products like PH-762, PH-894, and PH-804 for enhancing cancer immunotherapies in adoptive cell transfer.
Symbol: PHIO
Recent Price: $1.90
Industry: Biotechnology
CEO: Mr. Robert J. Bitterman
Sector: Healthcare
Employees: 8
Address: 257 Simarano Drive, Marlborough, MA 01752
Phone: 508 767 3861
Last updated: 2024-12-31
Regulus Therapeutics Inc.
RG-012 and RGLS8429
Regulus Therapeutics Inc., based in San Diego, focuses on discovering and developing drugs targeting micro RNAs for treating various diseases.
Symbol: RGLS
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Joseph P. Hagan M.B.A.
Sector: Healthcare
Employees: 30
Address: 4224 Campus Point Court, San Diego, CA 92121
Phone: 858 202 6300
Last updated: 2024-12-31
Rigel Pharmaceuticals, Inc.
Tavalisse
Rigel Pharmaceuticals, Inc. is a biotechnology company focused on discovering and developing small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases.
Symbol: RIGL
Recent Price: $16.47
Industry: Biotechnology
CEO: Mr. Raul R. Rodriguez
Sector: Healthcare
Employees: 147
Address: 1180 Veterans Boulevard, South San Francisco, CA 94080
Phone: 650 624 1100
Last updated: 2024-12-31
Rallybio Corporation
RLYB212
Rallybio Corporation is a clinical-stage biotechnology company focused on discovering, developing, manufacturing, and delivering therapies for severe and rare diseases, with a lead product candidate RLYB212 in clinical trials.
Contact | About | About | About | About | Careers | Careers | Careers | Careers | Careers | Careers | About | About
Symbol: RLYB
Recent Price: $0.93
Industry: Biotechnology
CEO: Dr. Stephen Uden M.B, M.D.
Sector: Healthcare
Employees: 25
Address: 234 Church Street, New Haven, CT 06510
Phone: 203 859 3820
Last updated: 2024-12-31
Rezolute, Inc.
RZ358
Rezolute, Inc. is a clinical stage biopharmaceutical company focused on developing transformative therapies for metabolic diseases related to chronic glucose imbalance. Its lead product, RZ358, is aimed at treating congenital hyperinsulinism.
Symbol: RZLT
Recent Price: $4.89
Industry: Biotechnology
CEO: Mr. Nevan Charles Elam J.D.
Sector: Healthcare
Employees: 59
Address: 201 Redwood Shores Parkway, Redwood City, CA 94065
Phone: 650 206 4507
Last updated: 2024-12-31
Sage Therapeutics, Inc.
ZULRESSO
Sage Therapeutics, Inc. is a biopharmaceutical company that develops and commercializes medicines for central nervous system disorders, with ZULRESSO for postpartum depression and a pipeline including zuranolone and SAGE-324 for various mood and neurological disorders.
About | About | Vision/Values | ESG | Leadership | About | ESG | Contact | Careers | Jobs | About | Careers | Jobs | Jobs | Careers | Culture | Careers | Careers | Careers | Careers | Careers | Locations | Benefits | Careers | DEI | Jobs | Jobs | Site Map | Careers | Careers | About | About | About | About | Jobs | Jobs
Symbol: SAGE
Recent Price: $5.43
Industry: Biotechnology
CEO: Mr. Barry E. Greene
Sector: Healthcare
Employees: 487
Address: 215 First Street, Cambridge, MA 02142
Phone: 617 299 8380
Leadership
- BARRY GREENE, Member of Board of Directors
- CHRIS BENECCHI, Chief Business Officer
- ANNE MARIE COOK, Senior Vice President, General Counsel
- LAURA GAULT, M.D., Ph.D., Chief Medical Officer
- PAMELA HERBSTER, Vice President, Head of People
- KIMI IGUCHI, Chief Financial Officer
- MATT LASMANIS, Chief Technology and Innovation Officer
- MIKE QUIRK, Ph.D., Chief Scientific Officer
- VANESSA PROCTER, Senior Vice President, External Affairs
- AMY SCHACTERLE, Ph.D., Senior Vice President, R&D Strategy and Business Management
- HEINRICH SCHLIEKER, Ph.D., Senior Vice President, Technical Operations
- LIZ BARRETT, President & Chief Executive Officer
- MICHAEL F. COLA,
- JESSICA FEDERER,
- JAMES M. FRATES,
- GENO GERMANO, CHAIR OF THE BOARD
- GEORGE GOLUMBESKI, Ph.D.,
- JEFF JONAS, M.D.,
Last updated: 2024-12-31
Summit Therapeutics Inc.
ridinilazole
Summit Therapeutics Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines to treat infectious diseases, with a lead product candidate called ridinilazole in Phase III clinical trials for Clostridioides difficile infection (CDI).
About | About | Leadership | Directors | About | About | Careers | About | News | About | About | About | About | ESG | About | About | About | About | About | About | Contact | About | About | About | About | About | About | About | Careers | Careers | Careers | Careers | Careers | Careers | About | About | Contact
Symbol: SMMT
Recent Price: $17.89
Industry: Biotechnology
CEO: Mr. Robert W. Duggan
Sector: Healthcare
Employees: 105
Address: One Broadway, Cambridge, MA 02142
Phone: 617 514 7149
Leadership
- Bob Duggan, CEO & Chairman
- Dr. Maky Zanganeh, CEO & President
- Dave Gancarz, Chief Business & Strategy Officer
- Dr. Urte Gayko, Chief Regulatory, Quality & Pharmacovigilance Officer
- Dr. Fong Clow, Chief Biometrics Officer
- Shelley D Spray, Chief Education & Brand Officer
- Dr. Allen S. Yang, Chief Medical Officer
- Bhaskar Anand, Head of Finance and Chief Accounting Officer
- Dr. Betty Chang, Head of Research, Oncology & Inflammation
- Dr. Andy Dwyer, Head of CMC & Supply Chain
- Dr. Noam Frey, SVP, Global Medical Affairs
- Pawan Parihar, Head of Information Technology
- Dr. Juthamas Sukbuntherng, Head of Clinical Pharmacology & DMPK
- Robert W. Duggan, CEO & Chairman of the Board
- Dr. Mahkam (Maky) Zanganeh, CEO, President & Director
- Manmeet Soni, Chief Operating Officer, Chief Financial Officer & Director
- Kenneth A. Clark, Lead Independent Director
- Dr. Robert Booth, Non-Executive Director
- Dr. Alessandra Cesano, Non-Executive Director
- Dr. Yu (Michelle) Xia, Director
- Dr. Mostafa Ronaghi, Non-Executive Director
- Jeff Huber, Non-Executive Director
Last updated: 2024-12-31
Xilio Therapeutics, Inc.
XTX101
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients with a focus on tumor-selective therapies.
Symbol: XLO
Recent Price: $0.97
Industry: Biotechnology
CEO: Dr. Rene Russo BCPS, Pharm.D.
Sector: Healthcare
Employees: 73
Address: 828 Winter Street, Waltham, MA 02451
Phone: 617 430 4680
Last updated: 2024-12-31
Unicycive Therapeutics, Inc.
Renazorb, UNI 494
Unicycive Therapeutics is a biotech company developing novel therapies for kidney diseases in the United States, focusing on treatments for hyperphosphatemia and acute kidney injury.
Symbol: UNCY
Recent Price: $0.58
Industry: Biotechnology
CEO: Dr. Shalabh K. Gupta M.D., MPA
Sector: Healthcare
Employees: 14
Address: 4300 El Camino Real, Los Altos, CA 94022
Phone: 650 351 4495
Last updated: 2024-11-08
Ionis Pharmaceuticals, Inc.
RNA-targeted therapeutics
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States, offering treatments like SPINRAZA, TEGSEDI, and WAYLIVRA, while developing medicines in phase 3 studies for various indications including TTR amyloidosis, severe hypertriglyceridemia, and amyotrophic lateral sclerosis.
About | About | About | DEI | DEI | DEI | DEI | Contact | Contact | Careers | Careers | Careers | Careers | Careers | Careers | About | About | News | About | About | ESG | DEI | DEI | About | About | About | Management | About | About | About | About | About | About | About | About | About | About | Careers | Careers | Careers | Careers | Careers | ESG | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About | About | About | About | Jobs | About | About
Symbol: IONS
Recent Price: $34.92
Industry: Biotechnology
CEO: Dr. Brett P. Monia Ph.D.
Sector: Healthcare
Employees: 927
Address: 2855 Gazelle Court, Carlsbad, CA 92010
Phone: 760 931 9200
Last updated: 2024-12-31